IMD Path is proud to announce our fully operational Flow Cytometry-10 Color program in the San Francisco Bay Area. We are capable of testing for Bone Marrow, Peripheral Blood, Body Fluid and Solid tissue samples with suspected Leukemia or Lymphoma diagnosis. This multiparameter flow cytometric immunophenotyping utilizes antibody panels specifically designed to characterize Hematolymphoid malignancies.
One of the unique benefits of our BD/FACS Canto 10-Color Flow Cytometry system includes the ability for maximal diagnostics/prognostic/predictive results with minimal specimen requirements. IMD Path’s 10-Color Flow Cytometric program is integrated to FDA approved FCS Express analysis software, enabling TC/PC capabilities, supported and managed by our Expert Flow Cytometry analyst team with over combined 40 years of experience.
Our focus is to improve overall service levels to Bay Area HematoOncology patients, while providing cost competitive services to mutual stakeholders i.e. Hospitals and Oncology patients, and simultaneously supporting and enabling a stronger strategic Pathology Business Model for Community based Pathology Groups.
ensures accurate, timely diagnosis of your Bay Area Patients.